Computed Phonetograms in Adult Patients with Benign Voice Disorders before and after Treatment with a Nonsedating Antihistamine (Loratadine)

1991 ◽  
Vol 43 (2) ◽  
pp. 60-67 ◽  
Author(s):  
M.F. Pedersen
Keyword(s):  
Voice Disorders ◽  
Adult Patients ◽  
Before And After

Interaction of Speech Coders and Atypical Speech II

2002 ◽  
Vol 45 (4) ◽  
pp. 689-699 ◽  
Author(s):  
Donald G. Jamieson ◽  
Vijay Parsa ◽  
Moneca C. Price ◽  
James Till
Keyword(s):  
Communication Systems ◽  
Speech Rate ◽  
Voice Quality ◽  
Voice Disorders ◽  
Normal Hearing ◽  
Speech Quality ◽  
Degraded Speech ◽  
Before And After ◽  
Subband Processing

We investigated how standard speech coders, currently used in modern communication systems, affect the quality of the speech of persons who have common speech and voice disorders. Three standardized speech coders (GSM 6.10 RPELTP, FS1016 CELP, and FS1015 LPC) and two speech coders based on subband processing were evaluated for their performance. Coder effects were assessed by measuring the quality of speech samples both before and after processing by the speech coders. Speech quality was rated by 10 listeners with normal hearing on 28 different scales representing pitch and loudness changes, speech rate, laryngeal and resonatory dysfunction, and coder-induced distortions. Results showed that (a) nine scale items were consistently and reliably rated by the listeners; (b) all coders degraded speech quality on these nine scales, with the GSM and CELP coders providing the better quality speech; and (c) interactions between coders and individual voices did occur on several voice quality scales.

Brain Perfusion in Adult Patients with Acute Myeloblastic Leukemia before and after Cytosine Arabinoside

2010 ◽  
Vol 13 (4) ◽  
pp. 747-753 ◽  
Author(s):  
Romain Modzelewski ◽  
Stéphane Lepretre ◽  
Olivier Martinaud ◽  
Didier Hannequin ◽  
Anne Hitzel ◽  
...  
Keyword(s):  
Cytosine Arabinoside ◽  
Brain Perfusion ◽  
Acute Myeloblastic Leukemia ◽  
Adult Patients ◽  
Before And After

Abstract TP366: Significant Reduction in Readmission Using Transitions Nurse

Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Kiersten Espaillat ◽  
Paula Buckner
Keyword(s):  
Hospital Discharge ◽  
Transitional Care ◽  
Medical Center ◽  
Hospital Readmissions ◽  
Primary Diagnosis ◽  
Adult Patients ◽  
Care Coordinator ◽  
Readmission Rates ◽  
Before And After

In an effort to reduce early hospital readmissions, Vanderbilt University Medical Center (VUMC) implemented a transitional care coordinator (TCC) to provide careful coordinated follow up care for stroke patients after hospital discharge. The aim of this study is to compare all cause thirty- day readmission rates of adult patients with a primary diagnosis of stroke before and after the implementation of a stroke services TCC. All adult patients admitted to VUMC with a primary diagnosis of stroke; ischemic, hemorrhagic, and TIA; and readmitted within the first thirty days following hospital discharge between January-June of 2015, 2016, 2017, & 2018 were analyzed. Readmission data from 2015 & 2016, prior to the implementation of the TCC was compared to readmission data from 2017 & 2018, after the TCC was implemented. A total of 1911 charts were reviewed for the timeframe January-June of 2015-2018. In 2015 there were 369 stroke admissions and 120 (33%) were readmitted and in 2016 there were 474 stroke admissions and 112 (24%) readmissions, before the TCC role was implemented. In 2017 there were 540 stroke admissions and 62 (11%) were readmitted and in 2018 there were 528 stroke admissions and 74 (14%) readmissions, after the TCC role was implemented. Hospital readmissions were reduced significantly after implementing a TCC.

scholarly journals Role of the nurse in preventing or reducing increase intracrani-al pressure following craniotomy

2017 ◽  
Vol 6 (2) ◽  
pp. 92
Author(s):  
Rasha Abdelmowla ◽  
Abdelhakeem Essa ◽  
Esmat Abdelmaged
Keyword(s):  
Intracranial Pressure ◽  
Educational Program ◽  
Demographic Data ◽  
Quality Care ◽  
Adult Patients ◽  
University Hospital ◽  
Control Group ◽  
Significant Difference ◽  
Before And After ◽  
Nurses Knowledge

Background: Increase intracranial pressure following craniotomy is common and different measures should be taken to prevent or treat it promptly. Aim: Preventing or reducing increase intracranial pressure following craniotomy. Research design: Quasi-experimental.Subjects and methods: All nurses (26) in neurosurgery department at Assiut Neurological, Psychiatric and Neurosurgery University Hospital, in addition to a sample of 124 patients after craniotomy. Control group (62 adult patients before implementing the nursing     educational program) and study group (62 adult patients after implementing the nursing educational program). Nurses’ knowledge and practice were assessed before and after implementation of the nursing educational program. Tools: Structured questionnaire to assess nurses` demographic data and knowledge about intracranial pressure, observation checklist for nurses` practice, patients’ assessment sheet, and teaching booklet for nurses about postoperative increase intracranial pressure. Results: Highly significant differences were found as regarding nurses` knowledge and nurses` practice pre and post implementing the nursing educational program. Significant difference was found between study and control groups as regarding increase intracranial pressure following craniotomy. Conclusion: Nursing educational program had a significant effect on preventing or reducing postoperative increase intracranial pressure.Recommendation: Nurses should have continuous education through programs, workshops, seminars and/or training courses to maintain high quality care.

Treatment Efficacy

1998 ◽  
Vol 41 (1) ◽  
Author(s):  
Lorraine Olson Ramig ◽  
Katherine Verdolini
Keyword(s):  
Medical Treatment ◽  
Voice Disorders ◽  
Voice Disorder ◽  
Future Research ◽  
Vocal Health ◽  
Physical Conditions ◽  
Voice Treatment ◽  
Before And After ◽  
The Voice

This article reviews the literature on the efficacy of treatment for voice disorders primarily using studies published in peer-reviewed journals. Voice disorders are defined, their frequency of occurrence across the life span is reported, and their impact on the lives of individuals with voice disorders is documented. The goal of voice treatment is to maximize vocal effectiveness given the existing disorder and to reduce the handicapping effect of the voice problem. Voice treatment may be (a) the preferred treatment to resolve the voice disorder when medical (surgical or pharmacological) treatments are not indicated; (b) the initial treatment in cases where medical treatment appears indicated; it may obviate the need for medical treatment; (c) completed before and after surgical treatment to maximize long-term post-surgical voice; and (d) a preventative treatment to preserve vocal health. Experimental and clinical data are reviewed that support these roles applied to various disorder types: (a) vocal misuse, hyperfunction and muscular imbalance (frequently resulting in edema, vocal nodules, polyps or contact ulcers); (b) medical or physical conditions (e.g., laryngeal nerve trauma, Parkinson disease); and (c) psychogenic disorders (e.g., conversion reactions, personality disorders). Directions for future research are suggested which maximize clinical outcomes and scientific rigor to enhance knowledge on the efficacy of voice treatment.

scholarly journals “Eight-drugs-in-one-day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas

Cancer ◽  
1989 ◽  
Vol 63 (12) ◽  
pp. 2475-2481 ◽  
Author(s):  
Jack M. Rozental ◽  
H. Ian Robins ◽  
Jonathan Finlay ◽  
Barbara Healey ◽  
Allan B. Levin ◽  
...  
Keyword(s):  
Malignant Gliomas ◽  
Adult Patients ◽  
Before And After

scholarly journals Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 4923-4923
Author(s):  
Phu-Quoc Le ◽  
Beatrice Gulbis ◽  
Laurence Dedeken ◽  
Laurence Rozen ◽  
Christiane Vermylen ◽  
...  
Keyword(s):  
Viral Infections ◽  
Conflicts Of Interest ◽  
Positive Impact ◽  
Adult Population ◽  
Median Number ◽  
Adult Patients ◽  
Acute Chest Syndrome ◽  
Acute Complications ◽  
Before And After

Abstract Survival among children and adults with SCD in Belgium published in 2015 showed a low mortality rate (0.25/100 patient years (PY)) among the 469 patients included (5,110 PY) with no significantly increase above 18 years of age. Hydroxyurea (HU) had a positive impact on patients' survival rate when compared to those without disease-modifying treatments (DMT) or transplanted. This led us to compare the incidence of acute complications and hospitalizations among children and adults to see if significant change occurred. Complications before and after the age of 18 for 84 patients with severe genotype followed after 18 years of age and not transplanted for whom the data during childhood were recorded in the registry are detailed in Figure 1 and Table I. Data on the pre- and post-18 years' events for the entire severe genotype cohort are detailed in Table II and include data from the patients under 18 years and data at the pediatric age of those more than 18 years. Data was censored from the time of the transplantation. Furthermore, data from adult patients before age 18 and beyond with severe genotype treated or not with HU are given in Table III. There were 139 patients (1759 PY) more than 18 years who had at last follow up a median age of 21 years (range: 18-53 years). 42% (59/139) of the patients were treated with HU. The median number of vaso-occlusive crisis (VOC) was statistically lower during adulthood (0 vs 29.6/100 PY; p= 0.007) and the median number of acute chest syndrome (ACS) was not statistically higher in adult period compared to their follow-up during childhood. Overall, severe infections as well as hospitalizations number (19 vs 63/100 PY; p=0.0006) and days (119 vs 259/100 PY; p=0.021) are significantly higher in children. The comparison of adults under HU and without DMT showed a significant higher incidence of acute events in HU patients (Table III). This is true for follow-up in childhood and beyond the age of 18 (Table III). Patients without DMT obviously seems to have attenuated symptomatology (clinical phenotype not very severe despite their severe genotype) and were therefore not considered benefiting from DMT. In the latter, no ACS was recorded during their follow-up in adulthood (Table III). The increase in CVO and ACS incidence with age is well described in the literature but not found in our results. Higher number of hospitalizations and infections before 18 years of age are observed. This can be explained by the fact that children consult more quickly and frequently and they are more readily monitored in hospital compared to adults. They also live in community, which increases the risk of seasonal viral infections. Compared with data available in the literature, our adult patients, most of whom are treated with HU, have fewer acute complications. Nevertheless the comparison is jeopardized because of different methodological approaches. In addition, our cohort of adult patients is limited, has a relatively short follow-up and consists mainly of adults under 21 at the last follow-up. The shorter length of follow up and the underrepresentation of older adults who pay a heavier toll on SCD because of co-existence of chronic complications, may explain the reduced incidence of acute complications in our cohort. In conclusion, the incidence of events observed in our adult population is lower than that described in the literature. This difference is probably related to a larger proportion of HU patients in our cohort. But these results should be confirmed by data from a larger number of adult patients with longer prospective follow-up. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document